Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2005 2
2009 2
2010 4
2011 4
2012 9
2013 3
2014 6
2015 7
2016 11
2017 7
2018 3
2019 4
2020 5
2021 7
2022 5
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Endometrial cancer.
Leslie KK, Thiel KW, Goodheart MJ, De Geest K, Jia Y, Yang S. Leslie KK, et al. Among authors: goodheart mj. Obstet Gynecol Clin North Am. 2012 Jun;39(2):255-68. doi: 10.1016/j.ogc.2012.04.001. Obstet Gynecol Clin North Am. 2012. PMID: 22640714 Free PMC article.
Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.
Praiss AM, Miller A, Smith J, Lichtman SM, Bookman M, Aghajanian C, Sabbatini P, Backes F, Cohn DE, Argenta P, Friedlander M, Goodheart MJ, Mutch DG, Gershenson DM, Tewari KS, Wenham RM, Wahner Hendrickson AE, Lee RB, Gray H, Secord AA, Van Le L, O'Cearbhaill RE. Praiss AM, et al. Among authors: goodheart mj. Gynecol Oncol. 2023 Jul;174:213-223. doi: 10.1016/j.ygyno.2023.05.013. Epub 2023 May 23. Gynecol Oncol. 2023. PMID: 37229879 Clinical Trial.
In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy.
Corvigno S, Badal S, Spradlin ML, Keating M, Pereira I, Stur E, Bayraktar E, Foster KI, Bateman NW, Barakat W, Darcy KM, Conrads TP, Maxwell GL, Lorenzi PL, Lutgendorf SK, Wen Y, Zhao L, Thaker PH, Goodheart MJ, Liu J, Fleming N, Lee S, Eberlin LS, Sood AK. Corvigno S, et al. Among authors: goodheart mj. NPJ Precis Oncol. 2023 Nov 3;7(1):115. doi: 10.1038/s41698-023-00454-0. NPJ Precis Oncol. 2023. PMID: 37923835 Free PMC article.
Disparity of ovarian cancer survival between urban and rural settings.
Ulmer KK, Greteman B, Cardillo N, Schneider A, McDonald M, Bender D, Goodheart MJ, Gonzalez Bosquet J. Ulmer KK, et al. Among authors: goodheart mj. Int J Gynecol Cancer. 2022 Apr 4;32(4):540-546. doi: 10.1136/ijgc-2021-003096. Int J Gynecol Cancer. 2022. PMID: 35197327 Free PMC article.
Prediction of chemo-response in serous ovarian cancer.
Gonzalez Bosquet J, Newtson AM, Chung RK, Thiel KW, Ginader T, Goodheart MJ, Leslie KK, Smith BJ. Gonzalez Bosquet J, et al. Among authors: goodheart mj. Mol Cancer. 2016 Oct 19;15(1):66. doi: 10.1186/s12943-016-0548-9. Mol Cancer. 2016. PMID: 27756408 Free PMC article.
82 results